Vapocoolant Spray to Reduce Pain With Nexplanon Insertion

Part of paid clinical trials in Honolulu, Hawaii.

Sponsor
Queen's Medical Center
Study ID
NCT06933381
Status
Recruiting

Conditions

  • Reducing Pain With Nexplanon Implant Insertion

Eligibility Criteria

Sex
FEMALE
Age
14 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Vapocoolant spray — DEVICE
    Pain Ease will be used per manufacturer instruction, applying the spray for 5 seconds or until the skin turns white, whichever occurs first.
  • Placebo — OTHER
    Nature's Tears will be applied to the arm as a placebo spray

Study Details

The purpose of this study is to assess if Pain Ease vapocoolant spray decreases pain associated with lidocaine injection during Nexplanon insertion procedures.

Key Dates

Start date
Jun 16, 2025
Status verified
Jan 2026
Primary completion
Apr 1, 2026
Completion
May 1, 2026

Study Design

Enrollment
70 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Vapocoolant Spray
    This is the study arm. Participants in this arm of the study will receive Pain Ease vapocoolant spray during their Nexplanon implant insertion in the arm. They will receive the spray on their arm right before lidocaine injection is administered for Nexplanon insertion procedure. Pain Ease vapocoolant spray is FDA approved for use on skin prior to common needle-stick procedures like intravenous (IV) starts and vaccines. The investigators will use the spray in a similar fashion, to help with the pain of lidocaine injection during Nexplanon insertion procedures. Physicians will do the Nexplanon procedure before any other procedures if patient has multiple procedures scheduled the same day.
  • Placebo Comparator: Nature's Tears
    This is the placebo. This group will receive Nature's Tears, which is a saline spray that does not offer analgesic effects.

Primary Outcome Measure

Pain with lidocaine injection [ Time Frame: Immediately after lidocaine injection ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Queens Medical Center POB 2 Suite 402HonoluluHawaii96813
Sarah Murayama, MD
808-783-0298
Mary Tschann, PhD
808-375-3785
Sarah Murayama, MD (PRINCIPAL_INVESTIGATOR)
Bliss Kaneshiro, MD MPH (PRINCIPAL_INVESTIGATOR)
Queens Medical Center POB1 Clinic 1004HonoluluHawaii96813
Sarah Murayama, MD
808-783-0298
Mary Tschann, PhD
808-375-3785
Sarah Murayama, MD (PRINCIPAL_INVESTIGATOR)
Bliss Kaneshiro, MD MPH (PRINCIPAL_INVESTIGATOR)
Women's Center Queen's North Hawai'i Community Hospital Suite #124 and #120WaimeaHawaii96743
Bliss Kaneshiro, MD, MPH
808-372-7560
Bliss Kaneshiro, MD, MPH (PRINCIPAL_INVESTIGATOR)

Find similar trials in Honolulu, HI